Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 173 (3), R131-51

Management of Endocrine Disease: Secondary Osteoporosis: Pathophysiology and Management


Management of Endocrine Disease: Secondary Osteoporosis: Pathophysiology and Management

Faryal Mirza et al. Eur J Endocrinol.


Osteoporosis is a skeletal disorder characterized by decreased mass and compromised bone strength predisposing to an increased risk of fractures. Although idiopathic osteoporosis is the most common form of osteoporosis, secondary factors may contribute to the bone loss and increased fracture risk in patients presenting with fragility fractures or osteoporosis. Several medical conditions and medications significantly increase the risk for bone loss and skeletal fragility. This review focuses on some of the common causes of osteoporosis, addressing the underlying mechanisms, diagnostic approach and treatment of low bone mass in the presence of these conditions.

Similar articles

  • Update on Medications With Adverse Skeletal Effects
    CJ Davidge Pitts et al. Mayo Clin Proc 86 (4), 338-43; quiz 343. PMID 21389249. - Review
    Patients rely on their primary care physician to manage multiple, often chronic medical conditions that require prescription medications. Balancing the risk to benefit of …
  • Drug-induced Osteoporosis: Mechanisms and Clinical Implications
    G Mazziotti et al. Am J Med 123 (10), 877-84. PMID 20920685. - Review
    Drug-induced osteoporosis is common and has a significant impact on the prognosis of patients suffering from chronic debilitating diseases. Glucocorticoids are the drugs …
  • Drug-induced Osteoporosis: Beyond Glucocorticoids
    K Briot et al. Curr Rheumatol Rep 10 (2), 102-9. PMID 18460264. - Review
    To prevent osteoporotic fractures, it is important to identify patients at high risk of fracture by assessing risk factors such as underlying diseases and drugs. Prior an …
  • Secondary Osteoporosis: Pathophysiology & Diagnosis
    GR Emkey et al. Best Pract Res Clin Endocrinol Metab 28 (6), 911-35. PMID 25432361. - Review
    Osteoporosis is a skeletal disease characterized by decreased bone mass and microarchitectural changes in bone tissue that increase the susceptibility to fracture. Second …
  • [Absolute Risk for Fracture and WHO Guideline. Treatment of Patients With Secondary Osteoporosis]
    M Yamauchi et al. Clin Calcium 17 (7), 1106-13. PMID 17607079. - Review
    There has been accumulating evidence that various diseases and drugs cause increased risk of fracture. Although the treatment of primary diseases and discontinuation of d …
See all similar articles

Cited by 24 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms